• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Watery diarrhoea and elevated vasoactive intestine polypeptide associated with a massive neurofibroma in early childhood.

作者信息

Carson D J, Glasgow J F, Ardill J

出版信息

J R Soc Med. 1980 Jan;73(1):69-72. doi: 10.1177/014107688007300117.

DOI:10.1177/014107688007300117
PMID:7230179
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1440026/
Abstract
摘要

相似文献

1
Watery diarrhoea and elevated vasoactive intestine polypeptide associated with a massive neurofibroma in early childhood.小儿期水样腹泻及血管活性肠肽升高与巨大神经纤维瘤相关。
J R Soc Med. 1980 Jan;73(1):69-72. doi: 10.1177/014107688007300117.
2
VIP: the cause of the watery diarrhoea syndrome.血管活性肠肽：水样腹泻综合征的病因。
Adv Exp Med Biol. 1978;106:195-201. doi: 10.1007/978-1-4684-7248-6_24.
3
[Sympathoma and diarrhea caused by hypersecretion of vasoactive intestinal peptide (VIP). Apropos of a further case].[血管活性肠肽（VIP）分泌过多引起的交感神经瘤与腹泻。附另一病例]
Arch Fr Pediatr. 1977 Jun-Jul;34(6):577-8.
4
Watery diarrhea syndrome with elevated levels of vasoactive intestinal polypeptide associated with pancreatitis and pancreatic pseudocyst.伴有血管活性肠肽水平升高的水样腹泻综合征，与胰腺炎和胰腺假性囊肿相关。
Am J Gastroenterol. 1978 Aug;70(2):136-40.
5
Plasma VIP in patients with watery diarrhea syndrome.
Am J Dig Dis. 1978 Apr;23(4):370-3. doi: 10.1007/BF01072424.
6
Vasoative intestinal peptide and the watery diarrhea syndrome.血管活性肠肽与水样腹泻综合征
Ann Surg. 1978 Apr;187(4):411-6. doi: 10.1097/00000658-197804000-00012.
7
Watery diarrhea syndrome. Two unusual cases and further evidence that VIP is a humoral mediator.水样腹泻综合征。两例罕见病例及关于血管活性肠肽是一种体液介质的进一步证据。
Ann Surg. 1978 Mar;187(3):325-8. doi: 10.1097/00000658-197803000-00020.
8
[Watery diarrhea in a child with ganglioneuroma and increased serum level of vasoactive intestinal hormone].[一名患有神经节神经瘤且血管活性肠肽血清水平升高的儿童出现水样腹泻]
Pediatr Pol. 1979 Sep;54(9):1053-8.
9
Watery diarrhoea with a vasoactive intestinal peptide-producing ganglioneuroblastoma.伴有分泌血管活性肠肽的神经节神经母细胞瘤的水样腹泻
Arch Dis Child. 1980 Dec;55(12):929-36. doi: 10.1136/adc.55.12.929.
10
Vasoactive intestinal peptide, the major mediator of the WDHA (pancreatic cholera) syndrome: value of measurement in diagnosis and treatment.
Am J Dig Dis. 1978 Apr;23(4):373-6. doi: 10.1007/BF01072425.

引用本文的文献

1
Rare Cases of Pediatric Vasoactive Intestinal Peptide Secreting Tumor With Literature Review: A Challenging Etiology of Chronic Diarrhea.小儿血管活性肠肽分泌肿瘤罕见病例及文献综述：慢性腹泻的一个具有挑战性的病因
Front Pediatr. 2020 Aug 5;8:430. doi: 10.3389/fped.2020.00430. eCollection 2020.

本文引用的文献

1
DIARRHEA IN A CHILD WITH A CATECHOLAMINE-SECRETING GANGLIONEUROMA. CASE REPORT AND REVIEW OF THE LITERATUTE.
J Pediatr. 1963 Aug;63:217-26. doi: 10.1016/s0022-3476(63)80332-7.
2
Endocrine manifestations of neurofibromatosis in children.儿童神经纤维瘤病的内分泌表现
Am J Dis Child. 1970 Sep;120(3):265-71. doi: 10.1001/archpedi.1970.02100080149020.
3
Neurofibromatosis in childhood.儿童神经纤维瘤病
J Pediatr. 1970 Mar;76(3):339-46. doi: 10.1016/s0022-3476(70)80472-3.
4
Vasoactive intestinal peptide and watery-diarrhoea syndrome.血管活性肠肽与水样腹泻综合征
Lancet. 1973 Jul 7;2(7819):14-6. doi: 10.1016/s0140-6736(73)91947-8.
5
Watery diarrhoea and ganglioneuroma with secretion of vasoactive intestinal peptide.水样腹泻与分泌血管活性肠肽的神经节神经瘤。
Arch Dis Child. 1975 Nov;50(11):896-9. doi: 10.1136/adc.50.11.896.
6
Intractable diarrhea in a boy with vasoactive intestinal peptide-producing ganglioneuroblastoma.一名患有分泌血管活性肠肽的神经节神经母细胞瘤男孩的顽固性腹泻。
Pediatrics. 1977 May;59(5):710-6.
7
Elevated plasma and tissue levels of vasoactive intestinal polypeptide in the watery-diarrhea syndrome due to pancreatic, bronchogenic and other tumors.因胰腺、支气管源性及其他肿瘤所致水样腹泻综合征中血管活性肠肽的血浆和组织水平升高。
N Engl J Med. 1975 Jul 24;293(4):155-60. doi: 10.1056/NEJM197507242930401.